Role of intravitreal bevacizumab in eales disease with dense vitreous hemorrhage: A prospective randomized control study

Retina

Volumn 31, Issue 5, 2011, Pages 866-870

  Patwardhan, Sourabh Dileep ^a   Azad, Rajvardhan ^a   Shah, Bhavin Mahendra ^a   Sharma, Yograj ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bevacizumab; Eales disease; tractional retinal detachment; vitrectomy; vitreous hemorrhage

Indexed keywords

BEVACIZUMAB;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EALES DISEASE; FOLLOW UP; HUMAN; INTERVENTION STUDY; INTRAOPERATIVE PERIOD; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADOLESCENT; ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; RETINAL VASCULITIS; RETREATMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; YOUNG ADULT;

EID: 79955562183     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181f2a27f     Document Type: Article

References (21)

1. Eales H. Retinal haemorrhage associated with epistaxis and constipation. Birmingham Med Rev 1880;9:262.
2. Eales H. Primary retinal haemorrhage in young men. Ophthalmic Rev 1882;1:41.
3. Gadkari SS, Kamdar PA, Jehangir RP, Shah NA, Adrianwala SD. Pars plana vitrectomy in vitreous hemorrhage due to Eales' disease. Indian J Ophthalmol 1992;40:35-37.
4. Patnaik B, Nagpal PN, Namperumalsamy P, Kalsi R. Eales' disease: clinical features, pathophysiology, etiopathogenesis. Ophthalmol Clin North Am 1998;11:601-617. (Pubitemid 29013298)
5. Biswas J, Sharma T, Gopal L, Madhavan H, Sulochana K, Ramakrishnan S. Eales disease-an update. Surv Ophthalmol 2002;47:197-214.
6. Kumar A, Tiwari HK, Sngh RP, Verma L, Prasad N. Comparative evaluation of early vs. deffered vitrectomy in Eales' disease. Acta Ophthalmol Scand 2000;78:77-78. (Pubitemid 30095317)
7. Shanmugam MP, Badrinath SS, Gopal L, Sharma T. Long term visual results of vitrectomy for Eales' disease complications. Int Ophthalmol 1998;22:61-64. (Pubitemid 29083239)
8. Shukla D, Kanungo S, Prasad NM, Kim R. Surgical outcomes for vitrectomy in Eales' disease. Eye 2008;22:900-904.
9. El-Asrar AM, Al-Kharashi SA. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease). Br J Ophthalmol 2002;86:1248-1251. (Pubitemid 35238606)
10. Atmaca LS, Nagpal PN. Eales' disease: medical, laser, and surgical treatments. Ophthalmol Clin North Am 1998;11: 619-626. (Pubitemid 29013299)
11. Smiddy WE, Isernhagen RD, Michels RG, Glaser BM, De Bustros SN. Vitrectomy for nondiabetic vitreous hemorrhage: retinal and choroidal vascular disorders. Retina 1988;8: 88-95.
12. Atmaca LS, Batioglu F, Sonmez PA. A long-term follow-up of Eales' disease. Ocul Immunol Inflamm 2002;10:213-221.
13. Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Mashayekhi A, Naghibozakerin J. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease. Eur J Ophthalmol 2005;15:379-383. (Pubitemid 40943937)
14. Kumar A, Sinha S. Rapid regression of disc and retinal neovascularisation in a case of Eales disease after intravitreal bevacizumab. Can J Ophthalmol 2007;42:335-336. (Pubitemid 46713702)
15. Kücxükerdönmez C, Akova YA, Yilmaz G. Intravitreal injection of bevacizumab in Eales disease. Ocul Immunol Inflamm 2008; 16:63-65. (Pubitemid 351480327)
16. Chanana B, Azad RV, Patwardhan S. Role of intravitreal bevacizumab in the management of Eales' disease. Int Ophthalmol 2010;30:57-61.
17. Raju B, Raju NS, Raju AS, Rajamma SP. Spontaneous relief of vitreomacular traction and regression of neovascularisation in Eales disease after intravitreal injection of bevacizumab. Retin Cases Brief Rep 2009;3:128-129.
18. Lieberman RM, Gow JA, Grillone LR. Development and implementation of a Vitreous Hemorrhage Grading Scale. Retin Physician 2006;3:S1-S8.
19. Perentes Y, Chan CC, Bovey E, Uffer S, Herbort CP. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease. Klin Monatsbl Augenheilkd 2002;219: 311-314. (Pubitemid 34625244)
20. Moradian S, Ahmadieh H, Malihi M, SoheilianM, DehghanMH, Azarmina M. Intravitreal Bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:1699-1705.
21. Arevalo JF, Maia M, Flynn HW, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216. (Pubitemid 351224097)